17th of March 2016, first ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised an interactive learning and networking experience. Here you can review one of the three lectures that were on the agenda: Quality of life of patients with MS: the ideal outcome.
When you look at the definition of paradigms you can highlight one word and that is care. Dr. Lysandropoulos wants to talk with all kind of care givers because MS is an important example of a disease in which you need a multi-disciplinary approach.
Why do we care about our patients? What is our goal when we treat them?
You have to go beyond treatment, you have to go to the part of the disease that is hidden, namely the quality of life.
is an MS specialist at the University Hospital “Erasme” in Brussels, BELGIUM. His major research interests are clinical spectrum of MS and CD8+ T cells, vitamin D, HLA and EBV in MS. He received his MD from Athens Medical School in Greece and completed his internship and residency in Neurology/Neuroimmunology at the University Hospital of Lausanne, Switzerland. At the same time, he developed his own research project at the Laboratory of Immunology of the University Hospital of Lausanne. Since June 2012, he is running the Neuroimmunology Unit at the University Hospital “Erasme” in Brussels. Dr. Lysandropoulos develops research projects in MS and participates as principal investigator to several clinical studies. He is the writer of medical articles in peer-reviewed journals and he is an invited author to national medical journals. Dr Lysandropoulos is a member of national and international MS advisory boards.